Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

76.45 +0.45 (+0.59%)
Streaming Delayed Price Updated: 12:03 PM EDT, Sep 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
37 38 Next >
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today
 
Via Benzinga
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
New medicines for weight loss and diabetes stand to disrupt the competitive scene. 
Via The Motley Fool
3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry-leading stocks that billionaire investors can't stop buying. 
Via The Motley Fool
2 Stock Split Growth Stocks to Buy and Hold
These companies could continue delivering excellent results long after their most recent stock splits are forgotten. 
Via The Motley Fool
Investing Lesson: Value Drivers
Trends come, trends go. So, how can investors spot the difference between another passing fad and something with real, sustainable value? 
Via The Motley Fool
Looking Into DexCom's Recent Short Interest
 
Via Benzinga
Is DexCom the Next Big Growth Stock?
It has significant growth drivers in play, but competitors are making inroads too. 
Via The Motley Fool
Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment &amp; Supplies Industry
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Could DexCom Stock Help You Become a Millionaire?
DexCom has achieved strong growth over the years, but there's a big question mark over how strong it will be in the future. 
Via The Motley Fool
Behind the Scenes of DexCom's Latest Options Trends
 
Via Benzinga
Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day
From DexCom, Inc.
Via Business Wire
This Is What Whales Are Betting On DexCom
 
Via Benzinga
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition.
NASDAQ:DXCM is not too expensive for the growth it is showing. 
Via Chartmill
Novo Nordisk, Eli Lilly Skid — But These Weight-Loss Results Are 'Hard To Ignore'
Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
3 Earnings Winners Poised to Outperform the Market
Discover three earnings winners that beat estimates and could help you beat the market, too. Which ones will you add to your portfolio? 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity
Investors could be making a mistake by selling off these stocks this year. 
Via The Motley Fool
Check Out What Whales Are Doing With DXCM
 
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,300 Today
 
Via Benzinga
DexCom Unusual Options Activity
 
Via Benzinga
3 Healthcare Stocks Getting Help From the Aging Population
America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions. 
Via InvestorPlace
1 Stock-Split Stock to Buy Hand Over Fist in November, and 1 to Avoid
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a phenomenally cheap industry leader, as well as an exceptionally pricey company... 
Via The Motley Fool
2 Growth Stocks That Could Help Set You Up for Life
These businesses have more beneath the surface than what their share prices might indicate. 
Via The Motley Fool
Analyzing DexCom In Comparison To Competitors In Health Care Equipment &amp; Supplies Industry
 
Via Benzinga
Exploring growth characteristics of DEXCOM INC (NASDAQ:DXCM).
High growth, ROE and beating expectations for NASDAQ:DXCM: growth investors may appreciate this. 
Via Chartmill
Barron's Weekend Stock Picks: Verizon, VF Corp And Altria's Dividend Yield
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024
Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc. 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.